1. 1407PDerived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients. (23rd October 2018) Authors: Mezquita, L; Arbour, K; Auclin, E; Saravia, D; Rizvi, H; Hendriks, L; Planchard, D; Park, W; Nadal, E; Ruffinelli Rodriguez, J C; Ponce, S; Audigier-Valette, C; Marilniello, A P; Zalcman, G; Majem, M; Schiavone, G; Dingemans, A-M C; Lopes, G; Hellmann, M D; Besse, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 17P Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients. (15th December 2019) Authors: Blanc-Durand, F; Auclin, E; Planchard, D; Aix, S Ponce; Hendriks, L; Sullivan, I G; Saravia, D; Routy, B; Castro, R Lopez; Pilotto, S; Aboubakar, F; Kassouf, E; Rodriguez, A; Martin, A Amores; Bluthgen, M V; Duchemann, B; Caramella, C; Nadal, E; Besse, B; Mezquita, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗